Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Cell Cycle (Georgetown, Tex.)
|
June 21, 2012
Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo
Laura Carrassa, Rosaria Chilà, Monica Lupi, et al.
Cells
|
April 10, 2019
CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences
Ekaterina Y Ilyechova, Elisa Bonaldi, Iurii A Orlov, et al.
Cells
|
July 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Elisa Caiola, Marika Colombo, Giovanna Sestito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
PRL-3 phosphatase is implicated in ovarian cancer growth
Federica Polato, Annamaria Codegoni, Robert Fruscio, et al.
Future Medicinal Chemistry
|
May 17, 2018
Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking
Fabiana Caporuscio, Annachiara Tinivella, Valentina Restelli, et al.
Scientific Reports
|
January 19, 2018
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
Elisa Caiola, Roberta Frapolli, Michele Tomanelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 9, 2016
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma
Mirko Marabese, Elisa Caiola, Marina C Garassino, et al.
Cancer Research
|
May 24, 2011
Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates
Marco Mazzoletti, Francesca Bortolin, Laura Brunelli, et al.
Cancer Treatment Reviews
|
June 5, 2016
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Marianna Macerelli, Monica Ganzinelli, Cedric Gouedard, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 6, 2018
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach
Elisa Caiola, Francesca Falcetta, Silvia Giordano, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Cell Cycle (Georgetown, Tex.)
|
June 21, 2012
Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo
Laura Carrassa, Rosaria Chilà, Monica Lupi, et al.
Cells
|
April 10, 2019
CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences
Ekaterina Y Ilyechova, Elisa Bonaldi, Iurii A Orlov, et al.
Cells
|
July 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Elisa Caiola, Marika Colombo, Giovanna Sestito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
PRL-3 phosphatase is implicated in ovarian cancer growth
Federica Polato, Annamaria Codegoni, Robert Fruscio, et al.
Future Medicinal Chemistry
|
May 17, 2018
Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking
Fabiana Caporuscio, Annachiara Tinivella, Valentina Restelli, et al.
Scientific Reports
|
January 19, 2018
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
Elisa Caiola, Roberta Frapolli, Michele Tomanelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 9, 2016
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma
Mirko Marabese, Elisa Caiola, Marina C Garassino, et al.
Cancer Research
|
May 24, 2011
Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates
Marco Mazzoletti, Francesca Bortolin, Laura Brunelli, et al.
Cancer Treatment Reviews
|
June 5, 2016
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Marianna Macerelli, Monica Ganzinelli, Cedric Gouedard, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 6, 2018
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach
Elisa Caiola, Francesca Falcetta, Silvia Giordano, et al.
Page
of 12